AllianceBernstein
ELOS

AllianceBernstein’s Syneron Medical Ltd ELOS Stock Holding History

AllianceBernstein’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-211
Closed -$3K – 3774
2014
Q1 		$3K Hold
211
– – ﹤0.01% 3397
2013
Q4 		$3K Hold
211
– – ﹤0.01% 3204
2013
Q3 		$2K Buy
+211
New +$1.82K ﹤0.01% 3307

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

AllianceBernstein's ELOS Position: Q2 2014 in Review

AllianceBernstein sold out of Syneron Medical Ltd (ELOS) in Q2 2014, closing a stake of 211 shares — an estimated $3K sold.

AllianceBernstein first reported a position in ELOS in Q3 2013 and held it in 3 quarters. The position peaked at $3K in Q1 2014. 61 funds tracked by Wall St. Rank hold ELOS as of Q2 2014.

  • AllianceBernstein reported no remaining Syneron Medical Ltd position as of Q2 2014 after selling out during the quarter.
  • AllianceBernstein sold 211 Syneron Medical Ltd shares in Q2 2014, an estimated $3K.
  • AllianceBernstein first reported a position in Syneron Medical Ltd in Q3 2013 and held it in 3 quarters.
  • AllianceBernstein's Syneron Medical Ltd position peaked at $3K in Q1 2014.
  • 61 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2014.

Based on AllianceBernstein's 13F filing for Q2 2014, filed 13 Aug 2014.